
The British Business Bank has committed €25 million to EQT Life Sciences' EQT Health Economics 3 Fund, supporting high-potential life sciences companies in the UK. This investment is part of the Bank's ongoing efforts to back the UK's life sciences sector, one of the eight growth sectors of the UK Industrial Strategy. The fund will focus on commercial-stage, de-risked medtech and digital health technologies.

Anthropic has unveiled Claude Science, a flagship AI product engineered to transform scientific research, particularly in computational biology and drug development. Positioned alongside Claude Code, this standalone offering empowers researchers to autonomously carry out complex tasks, marking a significant strategic leap for Anthropic into the life sciences domain and intensifying competition in AI for scientific discovery.

NVIDIA's BioNeMo Agent Toolkit now powers Anthropic's Claude Science, enabling researchers to accelerate drug discovery and genomic analysis with natural language workflows. This collaboration marries NVIDIA's GPU computing with Claude Science's AI agents for faster scientific innovation.
Get the top AI stories in your inbox once a day, no spam.
New stories are added every couple of hours as they break, so the feed stays current throughout the day.
We pull from 100+ sources, including company blogs, research labs, and established tech publications, then fact check and summarize each story before it goes live.
Yes. Use the sidebar filters to narrow stories down by company (OpenAI, Anthropic, Google, and more), industry, or event type like funding and research.
Yes. AI Pulse is free for anyone who wants to keep up with AI news, no sign up required. The daily newsletter is optional if you want updates in your inbox.